CHINA’S INTEREST IN BIOTECH DRUGS IS SPURRING INVESTMENTS. Capable of implementing very long-term and well-funded initiatives, China is becoming an influential player in world investment markets. The JPM breakout session a couple of years ago featured Chinese Pharma companies talking about brand drugs. This was a significant sea change, because it meant that they would enforce patent protection. Watch this space.
http://lnkd.in/Swa-RQ
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022